Related Experiment Videos
Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma.
Ignacio I Wistuba1, Carmen Behrens, Jorge Albores-Saavedra
1Departments of Anatomic Pathology, Pontificia Universidad Catolica de Chile, Santiago, Chile. iiwistuba@mdanderson.org
Summary
Signet ring cell colorectal carcinoma (SRCCC) shows a unique K-ras mutation pattern, differing significantly from usual colorectal cancer. This includes a specific codon 61 mutation rarely seen in other human tumors.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Signet ring cell colorectal carcinoma (SRCCC) is a rare and aggressive cancer.
- Understanding its molecular basis is crucial for targeted therapies.
Purpose of the Study:
- To investigate the molecular pathogenesis of SRCCC.
- To compare molecular abnormalities in SRCCC with usual colorectal adenocarcinoma.
Main Methods:
- K-ras mutations at codons 12, 13, and 61 analyzed in 16 SRCCCs and 27 non-SRCCCs.
- TP53 mutations, allele loss, and microsatellite instability assessed in a subset of tumors.
Main Results:
- SRCCC exhibited a distinct K-ras mutation pattern with significantly lower frequencies at codons 12 and 13 (13% vs. 48%).
- A specific K-ras codon 61 A:T transversion (CAA to CAT) was observed in 25% of SRCCCs, but not in non-SRCCCs or other signet ring cell carcinomas.
- TP53 mutation, allele loss, and microsatellite instability showed comparable frequencies between SRCCC and non-SRCCC.
Conclusions:
- SRCCC is characterized by a unique K-ras mutation profile.
- The specific K-ras codon 61 mutation identified in SRCCC is rare in human neoplasms.